SUSQUEHANNA INTERNATIONAL GROUP, LLP - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 233 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$1,203,821
-47.9%
354,065
+12.7%
0.00%
Q2 2023$2,309,466
-60.9%
314,213
-44.9%
0.00%
-100.0%
Q1 2023$5,904,558
+469.3%
569,938
+549.0%
0.00%
Q4 2022$1,037,131
-49.2%
87,818
-9.7%
0.00%
-100.0%
Q3 2022$2,042,000
-32.3%
97,269
+0.1%
0.00%
Q2 2022$3,018,000
-29.0%
97,211
-6.1%
0.00%
Q1 2022$4,252,000
-71.1%
103,581
-69.4%
0.00%
Q4 2021$14,712,000
+197.2%
338,436
+242.3%
0.00%
Q3 2021$4,951,000
-54.4%
98,882
-42.7%
0.00%
-100.0%
Q2 2021$10,864,000
-17.7%
172,472
+21.4%
0.00%
-66.7%
Q1 2021$13,204,000
-72.4%
142,109
-73.4%
0.00%
-25.0%
Q4 2020$47,888,000
+121.7%
534,454
+155.7%
0.00%
-20.0%
Q3 2020$21,597,000
+168.6%
209,010
+105.5%
0.01%
+150.0%
Q2 2020$8,041,000
+69.8%
101,684
+24.2%
0.00%
+100.0%
Q1 2020$4,736,000
+13.9%
81,847
+6.2%
0.00%0.0%
Q4 2019$4,157,000
-23.9%
77,048
-26.3%
0.00%
-50.0%
Q3 2019$5,466,000
-29.9%
104,558
-35.2%
0.00%
+100.0%
Q2 2019$7,802,000
+312.8%
161,473
+331.7%
0.00%0.0%
Q1 2019$1,890,000
+82.3%
37,400
+113.7%
0.00%
Q4 2018$1,037,000
-32.1%
17,500
-24.6%
0.00%
-100.0%
Q3 2018$1,527,000
+338.8%
23,200
+236.2%
0.00%
Q2 2018$348,000
-67.3%
6,900
-65.8%
0.00%
Q1 2018$1,064,000
-18.9%
20,200
-28.4%
0.00%
Q4 2017$1,312,000
-51.2%
28,214
-57.6%
0.00%
-100.0%
Q3 2017$2,690,000
+36.1%
66,500
+14.1%
0.00%0.0%
Q2 2017$1,977,000
+172.3%
58,300
+133.2%
0.00%
Q1 2017$726,000
-58.1%
25,000
-52.6%
0.00%
Q4 2016$1,732,000
+71.0%
52,750
+64.3%
0.00%
Q3 2016$1,013,000
-73.1%
32,100
-76.0%
0.00%
-100.0%
Q2 2016$3,765,000
-14.0%
133,900
+11.1%
0.00%0.0%
Q1 2016$4,380,000
+984.2%
120,500
+1093.1%
0.00%
Q4 2015$404,000
-41.1%
10,100
-58.0%
0.00%
Q3 2015$686,000
+22.3%
24,061
+41.4%
0.00%
Q2 2015$561,000
+6.2%
17,012
-7.3%
0.00%
Q1 2015$528,000
+60.0%
18,358
+51.6%
0.00%
Q4 2014$330,000
+51.4%
12,111
+24.9%
0.00%
Q2 2014$218,000
-69.0%
9,700
-65.2%
0.00%
Q1 2014$704,000
+20.5%
27,834
+9.6%
0.00%
Q4 2013$584,00025,4000.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Broadfin Capital, LLC 2,080,519$44,336,0004.65%
GREAT POINT PARTNERS LLC 290,000$6,180,0002.65%
FIDUCIARY MANAGEMENT ASSOCIATES LLC 651,884$13,892,0000.99%
Matarin Capital Management, LLC 85,003$1,811,414,0000.83%
KINGDON CAPITAL MANAGEMENT, L.L.C. 407,000$8,673,0000.39%
ICON ADVISERS INC/CO 258,478$5,508,0000.32%
RMB Capital Management, LLC 178,204$3,798,0000.23%
NEW AMSTERDAM PARTNERS LLC/NY 159,470$3,398,0000.23%
GLOBEFLEX CAPITAL L P 94,016$2,003,0000.23%
Convergence Investment Partners, LLC 58,672$1,250,0000.17%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders